KUALA LUMPUR, Jan 26 — Pharmaniaga Bhd’s unit, Pharmaniaga Lifescience Sdn Bhd (PLS), is expected to supply 12 million doses of Covid-19 vaccine developed by China-based Sinovac Life Sciences Co Ltd to the Ministry of Health (MOH) by April this year.
In a filing with Bursa Malaysia today, the company said PLS has submitted its application for registration with National Pharmaceutical Regulatory Agency (NPRA) on January 19, 2021.
“Subject to approval by the NPRA, the finished Covid-19 vaccine is expected to be delivered to MOH by April 2021,” it said.
Pharmaniaga said PLS has signed an agreement with the government for the purchase and distribution of Covid-19 CoronaVac, SARS-COV-2 Vaccine (Vero Cell) Inactivated to be delivered to hospitals, clinics and any other facilities nationwide as instructed by the MOH.
“The supply of the finished Covid-19 vaccine is subject to getting registered with drug control authority and meeting all regulatory requirements,” it said.
It said the agreement shall be effective from Jan 26, 2021, and remain in force for a period of one year, subject to earlier termination by either party for failing to meet the obligations or upon entering into the definitive agreement.
— Bernama
